| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 933.84M | 895.59M | 795.31M | 718.56M | 646.23M | 552.64M |
| Gross Profit | 225.76M | 209.73M | 171.69M | 158.26M | 152.11M | 123.62M |
| EBITDA | 165.83M | 150.36M | 121.35M | 109.67M | 108.43M | 82.61M |
| Net Income | 105.33M | 95.17M | 76.25M | 66.36M | 66.41M | 46.36M |
Balance Sheet | ||||||
| Total Assets | 611.68M | 545.98M | 454.68M | 393.92M | 415.25M | 424.76M |
| Cash, Cash Equivalents and Short-Term Investments | 207.45M | 170.58M | 105.56M | 71.33M | 97.50M | 139.72M |
| Total Debt | 18.57M | 28.08M | 31.40M | 33.76M | 43.14M | 54.66M |
| Total Liabilities | 248.90M | 223.99M | 207.03M | 191.75M | 202.85M | 204.36M |
| Stockholders Equity | 362.78M | 321.99M | 247.65M | 202.18M | 212.40M | 220.40M |
Cash Flow | ||||||
| Free Cash Flow | 101.19M | 91.56M | 70.00M | 55.97M | 37.40M | 77.14M |
| Operating Cash Flow | 144.60M | 127.31M | 99.24M | 82.29M | 67.22M | 94.38M |
| Investing Cash Flow | -43.41M | -35.76M | -29.24M | -26.32M | -29.82M | -17.24M |
| Financing Cash Flow | -32.09M | -26.54M | -35.76M | -82.14M | -79.61M | -20.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $3.81B | 36.63 | 32.63% | ― | 10.43% | 29.22% | |
72 Outperform | $1.61B | 64.65 | 8.79% | ― | 18.54% | -67.02% | |
71 Outperform | $27.47B | 24.14 | 10.47% | 0.76% | 17.87% | -9.35% | |
71 Outperform | $525.01M | 16.90 | 18.72% | 2.56% | 4.39% | 61.61% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $525.01M | 15.48 | 18.72% | 2.51% | 4.39% | 61.61% | |
49 Neutral | $2.73B | -80.03 | -4.63% | ― | 10.69% | 32.74% |
CorVel’s recent earnings call conveyed a generally positive sentiment, underscored by robust financial performance and significant advancements in AI technology. Despite facing challenges in the workers’ compensation labor market and pricing pressures in the commercial health segment, the company’s strong financial results and technological progress were the focal points of the discussion.
CorVel Corporation is a company specializing in risk management solutions, primarily within the healthcare and insurance sectors, known for leveraging technology to enhance service delivery.